Predictive In Vitro Models for Toxicity Testing and Liver Research

Having validated tools to perform predictive assays in a biologically-relevant system is key to success in drug discovery research. In this webinar, Dr. Terry Riss (Promega Corp) and Jennifer Christie (STEMCELL Technologies) discuss products and protocols that enable the incorporation of validated in vitro alternatives to animal models for toxicology studies. First, Dr. Riss presents in vitro assays for 3D cultures that monitor drug-induced cytotoxicity and explains how different assays can be multiplexed to measure multiple cell health parameters. Following this, Ms. Christie describes how to generate mature and functional hepatic organoids using HepatiCult™ and demonstrates their applications in liver research and hepatotoxicity assessment.

In this webinar, Dr. Terry Riss (Promega Corp) and Jennifer Christie (STEMCELL Technologies) discuss products and protocols for incorporating validated in vitro alternatives to animal models for toxicology studies. First, Dr. Riss presents in vitro assays in 3D cultures to monitor drug-induced cytotoxicity. Following this, Ms. Christie describes how to generate functional hepatic organoids using HepatiCult™ and demonstrates their applications in liver research and hepatotoxicity assessment.

Learn more about HepatiCult™ Organoid Media at http://www.HepatiCult.com.
Publish Date: May 09, 2023